US Patent Issued to Novartis on Sept. 23 for "Compounds and compositions for treating conditions associated with NLRP activity" (Massachusetts, New Jersey, Pennsylvania Inventors)

ALEXANDRIA, Va., Sept. 23 -- United States Patent no. 12,421,223, issued on Sept. 23, was assigned to Novartis AG (Basel, Switzerland).

"Compounds and compositions for treating conditions associated with NLRP activity" was invented by Shomir Ghosh (Brookline, Mass.), Jason Katz (Newton, Mass.), William Roush (Boston), Hans Martin Seidel (Concord, Mass.), Dong-Ming Shen (Edison, N.J.) and Shankar Venkatraman (Lansdale, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "In one aspect, compounds of Formula AA, or a pharmaceutically acceptable salt thereof, are featured: or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula A can be as defined anywhere herein."

The patent was fil...